0000899243-18-009224.txt : 20180403 0000899243-18-009224.hdr.sgml : 20180403 20180403161331 ACCESSION NUMBER: 0000899243-18-009224 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180331 FILED AS OF DATE: 20180403 DATE AS OF CHANGE: 20180403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Corvese Brian CENTRAL INDEX KEY: 0001393207 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 18733490 MAIL ADDRESS: STREET 1: C/O ANTIGENICS INC. STREET 2: 162 FIFTH AVENUE, SUITE 900 CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-31 0 0001098972 AGENUS INC AGEN 0001393207 Corvese Brian C/O AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02492 1 0 0 0 Common Stock 2018-03-31 4 M 0 21220 A 21220 D Restricted Stock Units 2018-03-31 4 M 0 21220 D Common Stock 21220 0 D Each restricted stock unit represents a contingent right to receive one share of common stock. Pursuant to the terms of the Restricted Stock Unit Award Agreement dated March 31, 2017, all 21,220 restricted stock units vested on March 31, 2018. Evan D. Kearns, by Power of Attorney 2018-04-03